The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of fruquintinib combined with chemotherapy versus bevacizumab combined with chemotherapy as second-line treatment for metastatic colorectal cancer: A prospective, multicenter, randomized controlled trial.
 
Jianmin Xu
No Relationships to Disclose
 
Wenju Chang
No Relationships to Disclose
 
Yu Liu
No Relationships to Disclose
 
Zizhen Zhang
No Relationships to Disclose
 
Ying Yuan
No Relationships to Disclose
 
Ren Zhao
No Relationships to Disclose
 
Xiaobing Chen
No Relationships to Disclose
 
Zhiquan Qin
No Relationships to Disclose
 
Zhangfa Song
No Relationships to Disclose
 
Guiying Wang
No Relationships to Disclose
 
Yong Dai
No Relationships to Disclose
 
Yanchang Xu
No Relationships to Disclose
 
Yong Mao
No Relationships to Disclose
 
Lingjun Zhu
No Relationships to Disclose
 
Shengxiang Rao
No Relationships to Disclose
 
Fei Liang
No Relationships to Disclose